[1] Pathak P, Xie C, Nichols RG, et al. Intestine farnesoid X receptor agonist and the gut microbiota activate G-protein bile acid receptor-1 signaling to improve metabolism.Hepatology,2018,68:1574-1588.
[2] Sayin SI, Wahlstr?m A, Felin J, et al. Gut microbiota regulates bile acid metabolism by reducing the levels of tauro-beta-muricholic acid,a naturally occurring FXR antagonist. Cell Metab. 2013,17:225-235.
[3] Alawad AS,Levy C. FXR Agonists: From Bench to Bedside, a Guide for Clinicians. Dig Dis Sci.2016, 61:3395-3404.
[4] Han CY. Update on FXR Biology: Promising Therapeutic Target?. Int J Mol Sci. 2018 , 19:pii: E2069.
[5] Roth JD, Feigh M, Veidal SS, et al. INT-767 improves histopathological features in a diet-induced ob/ob mouse model of biopsy-confirmed non-alcoholic steatohepatitis. World J Gastroenterol. 2018, 14,24:195-210. |
